Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705)
China
· Delayed Price · Currency is CNY 23.58
-0.12 (-0.51%)
Oct 11, 2024, 3:04 PM CST
Hunan Jiudian Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 454.76 | 368.26 | 269.7 | 204.25 | 82.26 | 55.07 | Upgrade
|
| Depreciation & Amortization | 79.56 | 69.3 | 59.7 | 53.58 | 48.24 | 37.35 | Upgrade
|
| Other Amortization | 5.09 | 3.46 | 1.04 | 1.03 | 0.88 | 0.49 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.03 | -0.03 | - | -0.02 | - | 0.12 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.48 | 1.46 | 0.39 | 0.88 | 10.99 | 5.63 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.54 | -2.13 | -1.84 | -2.85 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -1.63 | 7.59 | 12.77 | 5.36 | - | - | Upgrade
|
| Other Operating Activities | 27.66 | 18.27 | 24.37 | 31.78 | 5.25 | 4.68 | Upgrade
|
| Change in Accounts Receivable | 8.84 | -125.79 | -224.11 | -115.63 | -44.43 | 3.11 | Upgrade
|
| Change in Inventory | -34.6 | -24.06 | -32.1 | -76.92 | -23.99 | -29.07 | Upgrade
|
| Change in Accounts Payable | 106.25 | 112.06 | 138.62 | 100.75 | 76.66 | 23.83 | Upgrade
|
| Change in Other Net Operating Assets | 11.64 | 26.96 | 28.93 | - | -2.88 | -1.59 | Upgrade
|
| Operating Cash Flow | 651.73 | 431.19 | 268.99 | 190.87 | 149.99 | 90.74 | Upgrade
|
| Operating Cash Flow Growth | 52.54% | 60.30% | 40.93% | 27.25% | 65.30% | 32.99% | Upgrade
|
| Capital Expenditures | -365.82 | -426.82 | -413.38 | -125.93 | -78.35 | -181.99 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.48 | 0.15 | 0.13 | 0.27 | 0.05 | 3.06 | Upgrade
|
| Cash Acquisitions | - | - | - | -6.43 | - | - | Upgrade
|
| Investment in Securities | -113.12 | - | -20 | -100 | - | - | Upgrade
|
| Other Investing Activities | 2.07 | 2.1 | 1.9 | 2.54 | - | - | Upgrade
|
| Investing Cash Flow | -475.39 | -424.58 | -431.35 | -229.56 | -78.31 | -178.93 | Upgrade
|
| Long-Term Debt Issued | - | 157.8 | 314.76 | 53.7 | 19.9 | 115 | Upgrade
|
| Total Debt Issued | 127.7 | 157.8 | 314.76 | 53.7 | 19.9 | 115 | Upgrade
|
| Long-Term Debt Repaid | - | -364.09 | -124.44 | -17.75 | -71.63 | -54.53 | Upgrade
|
| Total Debt Repaid | -363.44 | -364.09 | -124.44 | -17.75 | -71.63 | -54.53 | Upgrade
|
| Net Debt Issued (Repaid) | -235.74 | -206.29 | 190.32 | 35.95 | -51.73 | 60.47 | Upgrade
|
| Issuance of Common Stock | 385.78 | 381.06 | - | 270 | - | - | Upgrade
|
| Common Dividends Paid | -118.68 | -94.62 | -69.3 | -15.01 | -13.77 | -15.49 | Upgrade
|
| Dividends Paid | -118.68 | -94.62 | -69.3 | -15.01 | -13.77 | -15.49 | Upgrade
|
| Other Financing Activities | -6.61 | -6.61 | - | -7.38 | - | - | Upgrade
|
| Financing Cash Flow | 24.75 | 73.55 | 121.02 | 283.56 | -65.5 | 44.98 | Upgrade
|
| Net Cash Flow | 201.09 | 80.16 | -41.35 | 244.88 | 6.19 | -43.21 | Upgrade
|
| Free Cash Flow | 285.91 | 4.37 | -144.39 | 64.94 | 71.64 | -91.25 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -9.35% | - | - | Upgrade
|
| Free Cash Flow Margin | 10.06% | 0.16% | -6.21% | 3.99% | 7.32% | -9.87% | Upgrade
|
| Free Cash Flow Per Share | 0.59 | 0.01 | -0.31 | 0.14 | 0.16 | -0.19 | Upgrade
|
| Cash Income Tax Paid | 326.05 | 302.22 | 243.22 | 188.16 | 104.61 | 98.83 | Upgrade
|
| Levered Free Cash Flow | -21.24 | -258.61 | -323.85 | 0.51 | 4.51 | -119.33 | Upgrade
|
| Unlevered Free Cash Flow | -9.16 | -251.7 | -312.34 | 10.52 | 7.79 | -116.41 | Upgrade
|
| Change in Net Working Capital | 23.8 | 146.11 | 155.38 | 50.17 | 11.82 | 5.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.